Efficacy Studies against PCV-2 of a New Trivalent Vaccine including PCV-2a and PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Weeks of Age

por Pleguezuelos, Patricia, Sibila, Marina, Ramírez, Carla, López-Jiménez, Rosa, Pérez, Diego, Huerta, Eva, Llorens, Anna Maria, Pérez, Mónica, Correa-Fiz, Florencia, Mancera Gracia, José Carlos, Taylor, Lucas P., Smith, Jennifer, Bandrick, Meggan, Borowski, Stasia, Saunders, Gillian, Segalés, Joaquim, López-Soria, Sergio, Fort, Maria, Balasch, Mónica
Publicado 2022